Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Priority to MYPI2020004677ApriorityCriticalpatent/MY208422A/en
Publication of MY208422ApublicationCriticalpatent/MY208422A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The present invention relates to the combination therapy of specific PD-1-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1. [No Suitable Figures]
MYPI2020004677A2020-09-092020-09-09Combination therapy of pd-1-targeted il-2 variant immunocytokines and antibodies against human pd-l1
MY208422A
(en)